KFSHRC PERFORMS WORLD-FIRST LIVER TRANSPLANT FOR RARE BLOOD DISORDER

KUALA LUMPUR, Aug 26 (Bernama) — King Faisal Specialist Hospital and Research Centre (KFSHRC) has successfully carried out the world’s first liver transplant on a patient with a rare genetic blood clotting disorder, capping 22 years of uninterrupted care for the same patient.

The patient, diagnosed with congenital plasminogen deficiency since infancy, had been under the hospital’s care since the first months of life.

The condition, caused by a lack of the plasminogen protein essential for dissolving blood clots, led to dangerous fibrous deposits affecting tissues and organs.

KFSHRC Adult Haematology and Stem Cell Transplant Division Director, Dr Hazzaa Al-Zahrani, who supervised the case, said the decision to proceed with a liver transplant was made after long-term management and careful consideration.

“The success of this procedure represents a turning point and a beacon of hope for patients worldwide facing similar conditions,” he said in a statement.

The patient’s father also expressed gratitude for the recovery, attributing it to the Kingdom’s advanced healthcare capabilities and government support.

The complexity of the case required a multidisciplinary approach that extended beyond medical care to include nursing, nutrition and information technology, alongside haematology and transplant specialists.

The treatment previously relied on regular intravenous doses of plasminogen and eye drops to preserve vision, at an annual cost exceeding six million Saudi riyals, fully covered by the Saudi government. (100 Saudi riyals = RM112.46)

This achievement underscores KFSHRC’s role as a global leader in rare disease management and transformative care, where science and compassion converge to redefine possibilities in medicine.

— BERNAMA

KFSHRC Saves Saudi 7-Year-Old Through Cross-Border Heart Transplant with UAE Donor Organ

RIYADH, Saudi Arabia, Aug 22 (Bernama-GLOBE NEWSWIRE) — King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed a life-saving heart transplant on a 7-year-old Saudi child using an organ donated by a brain-dead donor in Abu Dhabi, United Arab Emirates.

The complex procedure was made possible through seamless cross-border cooperation between the Saudi Center for Organ Transplantation and the UAE’s National Program for Donation and Transplantation of Human Organs and Tissue (HAYAT), with full consent from the donor’s family and all regulatory approvals in place.

This cooperation involved precise medical and logistical coordination, starting with the organ extraction, followed by air transportation to Riyadh, and concluding with the preparation of operating theaters in record time. The transplantation was performed within a critically time-sensitive window, ultimately saving the life of a child who had no other treatment options available.

The medical team at KFSHRC performed the transplantation on the child, who was suffering from advanced heart failure due to a complex congenital heart defect. After exhausting all available treatment options—including medications, respiratory support, and pacemaker implantation—without any significant improvement, the child was placed on the urgent transplant list.

Time is a critical factor in heart transplant operations. According to medical standards, the period between removing the heart from the donor and transplanting it into the patient must not exceed five hours to ensure transplant success. This time constraint creates significant logistical challenges in addition to the complex medical procedures, particularly when the brain-dead donor is located in another region within the Kingdom or overseas. In such circumstances, every minute of delay becomes crucial to the operation’s success.

The KFSHRC Heart Centre is recognized as one of the world’s leading cardiac centers, having achieved exceptional milestones including the world’s first fully robotic heart transplant and robotic artificial heart pump implantation without chest incision. These unprecedented medical breakthroughs demonstrate the Kingdom’s leadership in complex cardiac surgery.

KFSHRC has been ranked first in the Middle East and North Africa and 15th globally in the list of the world’s top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. It was included in the world’s best 250 hospitals and in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.

For more information, visit http://www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/aaf4d900-7f18-4871-9809-29e19875c14a

SOURCE: King Faisal Specialist Hospital & Research Centre

CGTN: Xizang’s development is a story of transformation and renewal

BEIJING, Aug 20 (Bernama-GLOBE NEWSWIRE) — The story of today’s Xizang Autonomous Region can’t be told in isolation. The profound transformation, resilience and renewal that people see today are a stark departure from the dark legacy of serfdom. It is a testament to the power of development guided by people-centered governance.

Once, at a two-day high-level meeting, Chinese President Xi Jinping called for further efforts to ensure national security and enduring peace and stability, steadily improve people’s lives, maintain a good environment, solidify border defense and ensure frontier security in Xizang. As an inseparable part of China, Xizang has always been a priority for the Central Government.

For centuries, ordinary Tibetans lived under the crushing weight of a feudal theocracy. Roughly 95 percent of the population were bound as serfs, deprived of land, education, and dignity. This old system preserved the privileges of a narrow elite while condemning the majority to poverty and powerlessness. The establishment of the People’s Government of the Xizang Autonomous Region marked a clear break from the past. People in Xizang transitioned from being oppressed serfs to citizens who became masters of their own fate.

The system of regional ethnic autonomy ensures that people of all ethnic groups are masters of their own affairs. As of 2025, Xizang has 42,153 deputies to the National People’s Congress at various levels, with ethnic minorities making up 89.2 percent of all local people’s congressional deputies. Over 57.17 percent of township-level party and government leaders are from minority backgrounds. And at the grassroots level, voter turnout exceeds 90 percent.

And the region’s economy boomed. The region’s GDP soared from just 174 million yuan (around $24.3 million) in 1959 to more than 276 billion yuan (around $38.5 billion) in 2024. Per capita disposable income reached over 31,000 yuan (around $4300), while absolute poverty – once a defining feature of life on the plateau – was eliminated by 2019, lifting 628,000 registered impoverished people out of hardship. Today, residents enjoy a steadily rising quality of life, with average life expectancy climbing from 35.5 years in 1951 to 72.5 years in 2024, reaching historic heights.

Education and healthcare are pillars of social progress. School-age students completing nine-year compulsory education have jumped from 2 percent to around 98 percent, while higher education enrollment exceeds 57 percent. And since 2015, medical aid programs have enabled local treatment for over 400 major conditions. Qu Dian, a 72-year-old Lhasa resident, had over 90 percent of his costs covered by insurance when he underwent cardiac surgery. “This would have been unimaginable in the old society,” he said.

The story of Xizang is also one of openness. Trade links now span 140 countries and regions, while tourism brought in 64 million visitors and 75 billion yuan in 2024. Local products like cordyceps (a genus of fungi used for centuries in Traditional Chinese Medicine) and yak wool reach global markets, and residents enjoy access to international goods with unprecedented ease.

It was nothing short of a rebirth for the region. The transformation it has experienced can’t be told separately from the depth of abjectness from where it started. From being oppressed and disregarded to becoming masters of its own affairs and prosperity, the decades of transformation brought Xizang to a level that would not have been dreamed of by people in the past. The snowy plateau has blossomed into a land of opportunity and hope – an achievement that speaks not just to Xizang’s people, but to the strength of a vision that places human well-being at the center of development.

Link:https://news.cgtn.com/news/2025-08-19/CGTN-Xizang-s-development-is-a-story-of-transformation-and-renewal-1FXXXuc4ZVu/p.html

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f8d27bcf-e16e-424e-9b08-84d319f4afc0

Contact:
CGTN Digital
Email: cgtn@cgtn.com

SOURCE: China Global Television Network Corporation

–BERNAMA

ALCON TO SHOWCASE NEXT-GEN EYE CARE TECH AT APACRS 2025 IN INDIA

KUALA LUMPUR, Aug 19 (Bernama) — Global eye care leader Alcon is set to make a major impact at the 37th Asia-Pacific Association of Cataract and Refractive Surgeons (APACRS) Annual Meeting, taking place Aug 21 to 23, in Ahmedabad, India.

The company will showcase four symposia, lead 10 medical affairs scientific exchange presentations, and offer a hands-on experience zone, spotlighting its latest surgical innovations backed by real-world evidence.

Alcon Asia Pacific Vice President, Surgical, Massimo Cerrone said surgeons at APACRS gain firsthand insights into how Alcon’s innovations meet the evolving demands of cataract care in the ageing population.

Through a dynamic agenda, surgeons can explore Alcon’s latest innovations and their value through clinical evidence, real-world insights, and peer experience across Asia-Pacific,” he said in a statement.

Meanwhile, Alcon India Country Head, Amar Vyas expressed pride in India hosting APACRS once again, using the platform to highlight advanced technologies designed to improve surgical precision and patient outcomes.

Clinical highlights include new data on Alcon’s Vivity intraocular lens (IOL)—a next-generation Extended Depth of Focus (EDOF) lens—showing high patient satisfaction in those with mild irregular astigmatism.

On the equipment front, Indian ophthalmologist Dr Shail Vasavada will present findings on retinal perfusion and intraocular pressure during cataract surgery in diabetic eyes.

Alcon will also officially launch its UNITY Vitreoretinal Cataract System (VCS) and UNITY Cataract System (CS) surgical platform in India, demonstrating advanced phaco and vitreoretinal capabilities.

Symposia topics range from IOL innovation to digital image guidance and surgical video demonstrations. Full details and registration are available via Alcon’s event platform.

— BERNAMA

EAACI LAUNCHES GLOBAL CAMPAIGN TO COMBAT ANTIBIOTIC ALLERGY MISLABELLING

KUALA LUMPUR, Aug 18 (Bernama) — The European Academy of Allergy and Clinical Immunology (EAACI) has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow, marking the start of a global initiative to address mislabelling and its link to antimicrobial resistance (AMR).

In a statement, the association said inaccurate antibiotic allergy labels affect millions of patients worldwide, leading to avoidance of first-line treatments and increased reliance on second-line antibiotics, a practice that fuels AMR.

EAACI is calling on stakeholders, including healthcare providers, policymakers and educators, to promote accurate diagnosis and responsible antibiotic use.

“We are launching a movement, not a moment. Too many lives are impacted by unverified allergy labels that limit treatment options and worsen outcomes. Correcting labels means saving lives, now and in the future,” said EAACI president, Prof Maria Torres.

The campaign aims to raise awareness of the dangers of incorrect allergy labels, empower patients and healthcare professionals with tools and training, promote evidence-based evaluation protocols and encourage rational antibiotic prescribing.

Outdated, unverified or self-reported allergy labels often reduce treatment options and increase risks, EAACI noted. The campaign seeks to overcome these barriers through education, training and advocacy.

A short educational video and a Promotional Kit 2025 form the backbone of the initiative, offering resources to spread awareness across multiple platforms.

Launched under the slogan “Correct Labels, Better Lives”, the campaign invites professionals, institutions and the public to participate in global efforts to safeguard the long-term effectiveness of antibiotics.

— BERNAMA